A regular internet blog written by Dr. Prodromos describing the latest advances in Stem Cell Medicine and related topics that you can use to help improve the health of yourself and your loved ones. (NOTE: your email address is kept strictly confidential)
Kidney disease is a condition in which the kidneys become damaged and cannot filter blood properly. Kidney disease affects over 660,000 Americans and leads to 47,000 deaths per year in the United States. People with high blood pressure and diabetes are at greater risk for kidney disease. Treatment for kidney disease can be very expensive, and patients can wait years for treatment.
Stem cell therapy has become an integral piece in the search for an innovative method to treat both Type 1 and Type 2 Diabetes, as the push to move away from regular insulin injections for patients continues. Mesenchymal stem cells’ ability to morph or differentiate into different types of cells in the body makes them a strong candidate to combat the condition that affects hundreds of millions of people worldwide.
Mesenchymal stem cells (MSCs) innately migrate toward areas of inflammation. Research shows that when administered intravenously, mesenchymal stem cells cross the blood-brain barrier leading to various therapeutic effects.
Stem cells are undifferentiated cells that can become multiple types of cells and reproduce continuously. There are two major types of stem cells: mesenchymal and embryonic. Mesenchymal stem cells have been shown potential to be useful in therapeutic procedures to treat diseases such as Alzheimer’s, kidney disease, cancer, and osteoarthritis. As stem cell therapy has become more popular and reliable, many myths and pieces of misinformation have arisen surrounding it.
Stem cells are undifferentiated cells which are defined by their ability to become multiple types of cells and their ability to proliferate indefinitely. Two of the most commonly talked about types of stem cells are mesenchymal and embryonic.
